Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Kidney Cancer Drug Market Size Growth Rate by Type (2014-2025) 1.4.2 Nexavar (Sorafenib) 1.4.3 Sutent (Sunitinib) 1.4.4 Afinitor (Everolimus) 1.4.5 Votrient (Pazopanib) 1.4.6 Avastin (Bevacizumab) 1.4.7 Inlyta (Axitinib), 1.4.8 Torisel (Temsirolimus) 1.4.9 Proleukin (Aldesleukin) 1.4.10 Other 1.5 Market by Application 1.5.1 Global Kidney Cancer Drug Market Share by Application (2014-2025) 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Research Center 1.5.5 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Kidney Cancer Drug Market Size 2.2 Kidney Cancer Drug Growth Trends by Regions 2.2.1 Kidney Cancer Drug Market Size by Regions (2014-2025) 2.2.2 Kidney Cancer Drug Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Kidney Cancer Drug Market Size by Manufacturers 3.1.1 Global Kidney Cancer Drug Revenue by Manufacturers (2014-2019) 3.1.2 Global Kidney Cancer Drug Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Kidney Cancer Drug Market Concentration Ratio (CR5 and HHI) 3.2 Kidney Cancer Drug Key Players Head office and Area Served 3.3 Key Players Kidney Cancer Drug Product/Solution/Service 3.4 Date of Enter into Kidney Cancer Drug Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Kidney Cancer Drug Market Size by Type (2014-2019) 4.2 Global Kidney Cancer Drug Market Size by Application (2014-2019) 5 United States 5.1 United States Kidney Cancer Drug Market Size (2014-2019) 5.2 Kidney Cancer Drug Key Players in United States 5.3 United States Kidney Cancer Drug Market Size by Type 5.4 United States Kidney Cancer Drug Market Size by Application 6 Europe 6.1 Europe Kidney Cancer Drug Market Size (2014-2019) 6.2 Kidney Cancer Drug Key Players in Europe 6.3 Europe Kidney Cancer Drug Market Size by Type 6.4 Europe Kidney Cancer Drug Market Size by Application 7 China 7.1 China Kidney Cancer Drug Market Size (2014-2019) 7.2 Kidney Cancer Drug Key Players in China 7.3 China Kidney Cancer Drug Market Size by Type 7.4 China Kidney Cancer Drug Market Size by Application 8 Japan 8.1 Japan Kidney Cancer Drug Market Size (2014-2019) 8.2 Kidney Cancer Drug Key Players in Japan 8.3 Japan Kidney Cancer Drug Market Size by Type 8.4 Japan Kidney Cancer Drug Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Kidney Cancer Drug Market Size (2014-2019) 9.2 Kidney Cancer Drug Key Players in Southeast Asia 9.3 Southeast Asia Kidney Cancer Drug Market Size by Type 9.4 Southeast Asia Kidney Cancer Drug Market Size by Application 10 India 10.1 India Kidney Cancer Drug Market Size (2014-2019) 10.2 Kidney Cancer Drug Key Players in India 10.3 India Kidney Cancer Drug Market Size by Type 10.4 India Kidney Cancer Drug Market Size by Application 11 Central & South America 11.1 Central & South America Kidney Cancer Drug Market Size (2014-2019) 11.2 Kidney Cancer Drug Key Players in Central & South America 11.3 Central & South America Kidney Cancer Drug Market Size by Type 11.4 Central & South America Kidney Cancer Drug Market Size by Application 12 International Players Profiles 12.1 Active Biotech 12.1.1 Active Biotech Company Details 12.1.2 Company Description and Business Overview 12.1.3 Kidney Cancer Drug Introduction 12.1.4 Active Biotech Revenue in Kidney Cancer Drug Business (2014-2019) 12.1.5 Active Biotech Recent Development 12.2 Amgen 12.2.1 Amgen Company Details 12.2.2 Company Description and Business Overview 12.2.3 Kidney Cancer Drug Introduction 12.2.4 Amgen Revenue in Kidney Cancer Drug Business (2014-2019) 12.2.5 Amgen Recent Development 12.3 Bayer AG 12.3.1 Bayer AG Company Details 12.3.2 Company Description and Business Overview 12.3.3 Kidney Cancer Drug Introduction 12.3.4 Bayer AG Revenue in Kidney Cancer Drug Business (2014-2019) 12.3.5 Bayer AG Recent Development 12.4 Cipla Limited 12.4.1 Cipla Limited Company Details 12.4.2 Company Description and Business Overview 12.4.3 Kidney Cancer Drug Introduction 12.4.4 Cipla Limited Revenue in Kidney Cancer Drug Business (2014-2019) 12.4.5 Cipla Limited Recent Development 12.5 F. Hoffmann-La Roche 12.5.1 F. Hoffmann-La Roche Company Details 12.5.2 Company Description and Business Overview 12.5.3 Kidney Cancer Drug Introduction 12.5.4 F. Hoffmann-La Roche Revenue in Kidney Cancer Drug Business (2014-2019) 12.5.5 F. Hoffmann-La Roche Recent Development 12.6 Genentech 12.6.1 Genentech Company Details 12.6.2 Company Description and Business Overview 12.6.3 Kidney Cancer Drug Introduction 12.6.4 Genentech Revenue in Kidney Cancer Drug Business (2014-2019) 12.6.5 Genentech Recent Development 12.7 Glaxosmithkline PLC 12.7.1 Glaxosmithkline PLC Company Details 12.7.2 Company Description and Business Overview 12.7.3 Kidney Cancer Drug Introduction 12.7.4 Glaxosmithkline PLC Revenue in Kidney Cancer Drug Business (2014-2019) 12.7.5 Glaxosmithkline PLC Recent Development 12.8 Novartis AG 12.8.1 Novartis AG Company Details 12.8.2 Company Description and Business Overview 12.8.3 Kidney Cancer Drug Introduction 12.8.4 Novartis AG Revenue in Kidney Cancer Drug Business (2014-2019) 12.8.5 Novartis AG Recent Development 12.9 Onyx Pharmaceuticals 12.9.1 Onyx Pharmaceuticals Company Details 12.9.2 Company Description and Business Overview 12.9.3 Kidney Cancer Drug Introduction 12.9.4 Onyx Pharmaceuticals Revenue in Kidney Cancer Drug Business (2014-2019) 12.9.5 Onyx Pharmaceuticals Recent Development 12.10 Pfizer 12.10.1 Pfizer Company Details 12.10.2 Company Description and Business Overview 12.10.3 Kidney Cancer Drug Introduction 12.10.4 Pfizer Revenue in Kidney Cancer Drug Business (2014-2019) 12.10.5 Pfizer Recent Development 12.11 Abbott Laboratories 12.12 Aveo Pharmaceuticals 12.13 Immatics Biotechnologies 12.14 Prometheus Laboratories 12.15 Exelixis 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Kidney Cancer Drug Key Market Segments Table Key Players Kidney Cancer Drug Covered Table Global Kidney Cancer Drug Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Kidney Cancer Drug Market Size Market Share by Type 2014-2025 Figure Nexavar (Sorafenib) Figures Table Key Players of Nexavar (Sorafenib) Figure Sutent (Sunitinib) Figures Table Key Players of Sutent (Sunitinib) Figure Afinitor (Everolimus) Figures Table Key Players of Afinitor (Everolimus) Figure Votrient (Pazopanib) Figures Table Key Players of Votrient (Pazopanib) Figure Avastin (Bevacizumab) Figures Table Key Players of Avastin (Bevacizumab) Figure Inlyta (Axitinib), Figures Table Key Players of Inlyta (Axitinib), Figure Torisel (Temsirolimus) Figures Table Key Players of Torisel (Temsirolimus) Figure Proleukin (Aldesleukin) Figures Table Key Players of Proleukin (Aldesleukin) Figure Other Figures Table Key Players of Other Table Global Kidney Cancer Drug Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals Case Studies Figure Clinics Case Studies Figure Research Center Case Studies Figure Other Case Studies Figure Kidney Cancer Drug Report Years Considered Table Global Kidney Cancer Drug Market Size 2014-2025 (Million US$) Figure Global Kidney Cancer Drug Market Size and Growth Rate 2014-2025 (Million US$) Table Global Kidney Cancer Drug Market Size by Regions 2014-2025 (Million US$) Table Global Kidney Cancer Drug Market Size by Regions 2014-2019 (Million US$) Table Global Kidney Cancer Drug Market Share by Regions 2014-2019 Figure Global Kidney Cancer Drug Market Share by Regions 2014-2019 Figure Global Kidney Cancer Drug Market Share by Regions 2019 Table Market Top Trends Table Global Kidney Cancer Drug Revenue by Manufacturers (2014-2019) (Million US$) Table Global Kidney Cancer Drug Market Share by Manufacturers (2014-2019) Figure Global Kidney Cancer Drug Market Share by Manufacturers in 2018 Table Global Kidney Cancer Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Kidney Cancer Drug Product/Solution/Service Table Date of Enter into Kidney Cancer Drug Market Table Mergers & Acquisitions, Expansion Plans Table Global Kidney Cancer Drug Market Size by Type (2014-2019) (Million US$) Table Global Kidney Cancer Drug Market Size Share by Type (2014-2019) Figure Global Kidney Cancer Drug Market Size Market Share by Type (2014-2019) Table Global Kidney Cancer Drug Market Size by Application (2014-2019) (Million US$) Table Global Kidney Cancer Drug Market Size Share by Application (2014-2019) Figure Global Kidney Cancer Drug Market Size Market Share by Application (2014-2019) Figure Global Kidney Cancer Drug Revenue Market Share by Application in 2018 Figure United States Kidney Cancer Drug Market Size 2014-2019 (Million US$) Table United States Key Players Kidney Cancer Drug Revenue (2018-2019) (Million US$) Table United States Key Players Kidney Cancer Drug Market Share (2018-2019) Table United States Kidney Cancer Drug Market Size by Type (2014-2019) (Million US$) Table United States Kidney Cancer Drug Market Share by Type (2014-2019) Table United States Kidney Cancer Drug Market Size by Application (2014-2019) (Million US$) Table United States Kidney Cancer Drug Market Share by Application (2014-2019) Figure Europe Kidney Cancer Drug Market Size 2014-2019 (Million US$) Table Europe Key Players Kidney Cancer Drug Revenue (2018-2019) (Million US$) Table Europe Key Players Kidney Cancer Drug Market Share (2018-2019) Table Europe Kidney Cancer Drug Market Size by Type (2014-2019) (Million US$) Table Europe Kidney Cancer Drug Market Share by Type (2014-2019) Table Europe Kidney Cancer Drug Market Size by Application (2014-2019) (Million US$) Table Europe Kidney Cancer Drug Market Share by Application (2014-2019) Figure China Kidney Cancer Drug Market Size 2014-2019 (Million US$) Table China Key Players Kidney Cancer Drug Revenue (2018-2019) (Million US$) Table China Key Players Kidney Cancer Drug Market Share (2018-2019) Table China Kidney Cancer Drug Market Size by Type (2014-20189) (Million US$) Table China Kidney Cancer Drug Market Share by Type (2014-2019) Table China Kidney Cancer Drug Market Size by Application (2014-2019) (Million US$) Table China Kidney Cancer Drug Market Share by Application (2014-2019) Figure Japan Kidney Cancer Drug Market Size 2014-2019 (Million US$) Table Japan Key Players Kidney Cancer Drug Revenue (2018-2019) (Million US$) Table Japan Key Players Kidney Cancer Drug Market Share (2018-2019) Table Japan Kidney Cancer Drug Market Size by Type (2014-2019) (Million US$) Table Japan Kidney Cancer Drug Market Share by Type (2014-2019) Table Japan Kidney Cancer Drug Market Size by Application (2014-2019) (Million US$) Table Japan Kidney Cancer Drug Market Share by Application (2014-2019) Figure Southeast Asia Kidney Cancer Drug Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Kidney Cancer Drug Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Kidney Cancer Drug Market Share (2018-2019) Table Southeast Asia Kidney Cancer Drug Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Kidney Cancer Drug Market Share by Type (2014-2019) Table Southeast Asia Kidney Cancer Drug Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Kidney Cancer Drug Market Share by Application (2014-2019) Figure India Kidney Cancer Drug Market Size 2014-2019 (Million US$) Table India Key Players Kidney Cancer Drug Revenue (2018-2019) (Million US$) Table India Key Players Kidney Cancer Drug Market Share (2018-2019) Table India Kidney Cancer Drug Market Size by Type (2014-2019) (Million US$) Table India Kidney Cancer Drug Market Share by Type (2014-2019) Table India Kidney Cancer Drug Market Size by Application (2014-2019) (Million US$) Table India Kidney Cancer Drug Market Share by Application (2014-2019) Figure Central & South America Kidney Cancer Drug Market Size 2014-2019 (Million US$) Table Central & South America Key Players Kidney Cancer Drug Revenue (2018-2019) (Million US$) Table Central & South America Key Players Kidney Cancer Drug Market Share (2018-2019) Table Central & South America Kidney Cancer Drug Market Size by Type (2014-2019) (Million US$) Table Central & South America Kidney Cancer Drug Market Share by Type (2014-2019) Table Central & South America Kidney Cancer Drug Market Size by Application (2014-2019) (Million US$) Table Central & South America Kidney Cancer Drug Market Share by Application (2014-2019) Table Active Biotech Company Details Table Active Biotech Revenue in Kidney Cancer Drug Business (2014-2019) (Million US$) Figure Active Biotech Revenue Growth Rate in Kidney Cancer Drug Business (2014-2019) Table Active Biotech Recent Development Table Amgen Company Details Table Amgen Revenue in Kidney Cancer Drug Business (2014-2019)(Million US$) Figure Amgen Revenue Growth Rate in Kidney Cancer Drug Business (2014-2019) Table Amgen Recent Development Table Bayer AG Company Details Table Bayer AG Revenue in Kidney Cancer Drug Business (2014-2019)(Million US$) Figure Bayer AG Revenue Growth Rate in Kidney Cancer Drug Business (2014-2019) Table Bayer AG Recent Development Table Cipla Limited Company Details Table Cipla Limited Revenue in Kidney Cancer Drug Business (2014-2019)(Million US$) Figure Cipla Limited Revenue Growth Rate in Kidney Cancer Drug Business (2014-2019) Table Cipla Limited Recent Development Table F. Hoffmann-La Roche Company Details Table F. Hoffmann-La Roche Revenue in Kidney Cancer Drug Business (2014-2019)(Million US$) Figure F. Hoffmann-La Roche Revenue Growth Rate in Kidney Cancer Drug Business (2014-2019) Table F. Hoffmann-La Roche Recent Development Table Genentech Company Details Table Genentech Revenue in Kidney Cancer Drug Business (2014-2019)(Million US$) Figure Genentech Revenue Growth Rate in Kidney Cancer Drug Business (2014-2019) Table Genentech Recent Development Table Glaxosmithkline PLC Company Details Table Glaxosmithkline PLC Revenue in Kidney Cancer Drug Business (2014-2019)(Million US$) Figure Glaxosmithkline PLC Revenue Growth Rate in Kidney Cancer Drug Business (2014-2019) Table Glaxosmithkline PLC Recent Development Table Novartis AG Company Details Table Novartis AG Revenue in Kidney Cancer Drug Business (2014-2019)(Million US$) Figure Novartis AG Revenue Growth Rate in Kidney Cancer Drug Business (2014-2019) Table Novartis AG Recent Development Table Onyx Pharmaceuticals Company Details Table Onyx Pharmaceuticals Revenue in Kidney Cancer Drug Business (2014-2019)(Million US$) Figure Onyx Pharmaceuticals Revenue Growth Rate in Kidney Cancer Drug Business (2014-2019) Table Onyx Pharmaceuticals Recent Development Table Pfizer Company Details Table Pfizer Revenue in Kidney Cancer Drug Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in Kidney Cancer Drug Business (2014-2019) Table Pfizer Recent Development Table Abbott Laboratories Company Details Table Aveo Pharmaceuticals Company Details Table Immatics Biotechnologies Company Details Table Prometheus Laboratories Company Details Table Exelixis Company Details Table Global Kidney Cancer Drug Market Size by Regions (Million US$) 2019-2025 Figure Global Kidney Cancer Drug Market Size Share by Regions (2019-2025) Figure Global Kidney Cancer Drug Market Size Share by Regions in 2025 Figure United States Kidney Cancer Drug Market Size Forecast (2019-2025)(Million USD) Figure Europe Kidney Cancer Drug Market Size Forecast (2019-2025)(Million USD) Figure China Kidney Cancer Drug Market Size Forecast (2019-2025)(Million USD) Figure Japan Kidney Cancer Drug Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Kidney Cancer Drug Market Size Forecast (2019-2025)(Million USD) Figure India Kidney Cancer Drug Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Kidney Cancer Drug Market Size Forecast (2019-2025)(Million USD) Table Global Kidney Cancer Drug Market Size by Product (2019-2025) (Million US$) Figure Global Kidney Cancer Drug Market Size by Product (2019-2025) Figure Global Kidney Cancer Drug Market Size by Product in 2025 Table Global Kidney Cancer Drug Market Size by Application (2019-2025) (Million US$) Figure Global Kidney Cancer Drug Market Size by Application (2019-2025) Figure Global Kidney Cancer Drug Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Active Biotech Amgen Bayer AG Cipla Limited F. Hoffmann-La Roche Genentech Glaxosmithkline PLC Novartis AG Onyx Pharmaceuticals Pfizer Abbott Laboratories Aveo Pharmaceuticals Immatics Biotechnologies Prometheus Laboratories Exelixis